Menu
Four major drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2022 and 2024.

Four Drugmakers to Refund 340B Covered Entities for Overcharges

Shannon Young, Associate Editor/Senior Writer 340B Report Views
Four major drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2022 and 2024, following recalculations [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Post Navigation

Carter, Harshbarger Reintroduce Controversial 340B ACCESS Act in U.S. House—This Time Without a Key Supporter

Federal Appeals Court Hears Arguments in Texas Hospitals’ Lawsuit Challenging DSH Calculation Changes

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live